| Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol M Razzak, A Johnson, J Goswami, A Awasthi US Patent App. 12/621,208, 2010 | 52 | 2010 |
| An overview on chemical derivatization and stability aspects of selected avermectin derivatives A Awasthi, M Razzak, R Al-Kassas, J Harvey, S Garg Chemical and Pharmaceutical Bulletin 60 (8), 931-944, 2012 | 45 | 2012 |
| Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR A Awasthi, M Razzak, R Al-Kassas, DR Greenwood, J Harvey, S Garg Analytical and bioanalytical chemistry 404, 2203-2222, 2012 | 23 | 2012 |
| Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMR A Awasthi, M Razzak, R Al-Kassas, DR Greenwood, J Harvey, S Garg Journal of pharmaceutical and biomedical analysis 63, 62-73, 2012 | 22 | 2012 |
| Selective separation and characterisation of stress degradation products and process impurities of prucalopride succinate by LC-QTOF-MS/MS BS Mahamuni, A Jajula, A Awasthi, PD Kalariya, MVNK Talluri Journal of pharmaceutical and biomedical analysis 125, 219-228, 2016 | 20 | 2016 |
| Analytical profile of moxidectin A Awasthi, M Razzak, R Al-Kassas, J Harvey, S Garg Profiles of drug substances, excipients and related methodology 38, 315-366, 2013 | 19 | 2013 |
| The novel acid degradation products of losartan: Isolation and characterization using Q-TOF, 2D-NMR and FTIR AK Pandey, R Rapolu, CK Raju, G Sasalamari, SK Goud, A Awasthi, ... Journal of Pharmaceutical and Biomedical Analysis 120, 65-71, 2016 | 17 | 2016 |
| Isolation and characterization of a novel acid degradation impurity of amlodipine besylate using Q-TOF, NMR, IR and single crystal X-ray R Rapolu, CK Raju, K Srinivas, A Awasthi, SG Navalgund, ... Journal of Pharmaceutical and Biomedical Analysis 99, 59-66, 2014 | 14 | 2014 |
| A novel UV degradation product of ebastine: isolation and characterization using Q-TOF, NMR, IR and computational chemistry R Rapolu, AK Pandey, CK Raju, K Ghosh, K Srinivas, A Awasthi, ... Journal of Pharmaceutical and Biomedical Analysis 107, 488-494, 2015 | 13 | 2015 |
| Separation and identification of degradation products in abamectin formulation using LC, LTQ FT-MS, H/D exchange and NMR A Awasthi, M Razzak, R Al-Kassas, D R. Greenwood, J Harvey, S Garg Current Pharmaceutical Analysis 8 (4), 415-430, 2012 | 8 | 2012 |
| Evaluation of degradation kinetics for abamectin in formulations using a stability indicating method A Awasthi, M Razzak, R Al-Kassas, J Harvey, S Garg Acta Pharmaceutica 63 (1), 59-69, 2013 | 6 | 2013 |
| Analytical Profile of Moxidectin. Profiles of Drug Substances, Excipients, and Related Methodology A Awasthi, M Razzak, R Al-Kassas, J Harvey, S Garg Academic Press 1 (38), 315-336, 2013 | 4 | 2013 |
| Injectable parasiticidal formulations of levamisole and macrocyclic lactones R Holmes, M Razzak, A Johnson, J Goswami, A Awasthi US Patent App. 13/106,677, 2011 | 2 | 2011 |
| Intramammary teat sealant M Razzak, R Holmes, A Johnson, J Goswami, A Awasthi US Patent App. 12/630,521, 2010 | 2 | 2010 |
| Stability evaluation of selected anthelmintic macrocyclic lactone compounds and formulations A Awasthi PhD Thesis-University of Auckland, 2012 | 1 | 2012 |
| Novel dicyclanil-based shelf stable aqueous suspension and non-aqueous solution pour-on and spray-on formulations useful for the prevention and treatment of insect infestation … M Razzak, A Johnson, J Goswami, A Awasthi, R Holmes US Patent App. 12/886,834, 2011 | 1 | 2011 |
